Investors
Proven ROI with long-term results.
One of the most exciting companies on the ASX 200.
Visage Imaging – Pro Medicus Limited
Visage Imaging is a global provider of enterprise imaging solutions that enable PACS replacement with local, regional and national scale.
The Visage® 7 Enterprise Imaging Platform is proven, providing a fast, clinically rich, and highly scalable growth platform deliverable entirely from the cloud or on premise. Visage 7 supports the simplicity of a One Viewer™ philosophy, that enables diagnostic, clinical, specialty, research, and mobile imaging workflows from a singular platform. Visage also offers modular scalability and future-proof flexibility with enterprise workflow (Visage 7 Workflow), vendor-neutral archive (Visage 7 Open Archive) and artificial intelligence (Visage AI Accelerator) solutions, all 100% native.
Visage Imaging is a wholly-owned subsidiary of Pro Medicus Limited, with more than 30 years of experience in medical imaging. Pro Medicus Limited shares are traded on the Australian Securities Exchange (ASX), under the symbol “PME” [ASX:PME].
Annual Reports & Annual General Meeting
Pro Medicus Limited “Pro Medicus” was initially listed on the Australian Securities Exchange on October 10, 2000, and on August 1, 2019, was added to the ASX 200.
Pro Medicus Annual Reports, as well as Pro Medicus Annual General Meeting (AGM) presentations may be found here. Please review the Pro Medicus website, or the Pro Medicus [ASX:PME] page on the ASX website for additional information. If you are interested in annual reports from prior years, click here.
